![]() | 1010 Atlantic Ave, Ste. 102 Alameda, CA 94501 T:510.521.3390 - F:510.521.3389 |
October 18, 2016
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549-4561
Attn: | Suzanne Hayes |
Mary Beth Breslin
Michael Gershon
Re: | OncoCyte Corporation |
Registration Statement on Form S-1
File No. 333-213810
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, OncoCyte Corporation hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement to 4:00 p.m., Eastern Time, on Thursday, October 20, 2016, or as soon thereafter as practicable.
Thank you for your assistance. Should you have any questions, please contact Andrew Ledbetter of DLA Piper LLP (US) at (206) 839-4845, or his colleague Kevin Criddle at (206) 839-4857.
Very truly yours,
OncoCyte Corporation
/s/ William Annett | |
William Annett | |
President and Chief Executive Officer |